Description: Valitor is engineering disruptive medicines that optimize how and where disease mechanisms are targeted to produce the most significant clinical impact. VLTR-557, is in development to become as a long-acting treatment for wet age-related macular degeneration (AMD)
Technology
Engineering better medicines. Conquering drug limitations. About About Valitor Valitor is conquering limitations of established drug targets by leveraging its multi-valent biopolymer technology to maximize benefits for patients.
The company is engineering disruptive medicines that optimize how and where disease mechanisms are targeted to produce the most significant clinical impact.